Sarah Alter
Altor BioScience (United States)(US)
Publications by Year
Research Areas
Immune Cell Function and Interaction, CAR-T cell therapy research, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models(2015)222 cited
- → In senescence, age‐associated B cells secrete TNFα and inhibit survival of B‐cell precursors*(2013)176 cited
- → IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas(2016)156 cited
- → Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy(2019)111 cited
- → Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model(2015)103 cited
- → Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells(2018)84 cited
- → A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses(2016)77 cited
- → Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models(2018)37 cited
- → Reliability and Validity of a Functional Cognition Screening Tool to Identify the Need for Occupational Therapy(2019)26 cited
- → Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model(2019)25 cited